A Questionnaire Survey on the Sequence of Events Prior to Undergoing Colonoscopy: The Influence of the Behavioral Response after a Fecal Occult Blood Test on the Early Detection of Colorectal Cancer.


Journal

Internal medicine (Tokyo, Japan)
ISSN: 1349-7235
Titre abrégé: Intern Med
Pays: Japan
ID NLM: 9204241

Informations de publication

Date de publication:
01 Jun 2019
Historique:
pubmed: 5 2 2019
medline: 14 8 2019
entrez: 5 2 2019
Statut: ppublish

Résumé

Objective The fecal occult blood (FOB) test is commonly used for colorectal cancer screening; however, it is uncertain if further diagnostic interventions, such as a colonoscopy, should be performed based on its results. Method To better understand patient behavior following the FOB test, 6,414 patients (3,807 men and 2,607 women) who underwent colonoscopy between August 2015 and March 2016 at any of the 26 medical institutions throughout Hiroshima Prefecture were invited to participate in the study. All patients provided their written consent, after which they completed a questionnaire, and their colonoscopy results were obtained. These datasets were analyzed in a blinded manner, and the unique codes linking the records were revealed at the end of the analysis. Results Of the total study population, 4,749 patients (74.0%) had previously undergone FOB testing. After classification of common behavioral responses that the patients displayed following their FOB test, the group who had undergone the test several times, who had not had positive test results in the past, and whose latest FOB test results were positive had a significantly higher diagnosis rate of both early- and advanced-stage cancer than the other groups. Furthermore, patients in whom several previous FOB test results had been negative whose previous colonoscopy was positive were associated with a higher diagnosis rate of early-stage cancer than other groups. Conclusion These results suggested that colonoscopy should be performed immediately for patients with positive FOB test results due to their association with colorectal cancer and the possible detection of cancer at an early stage.

Identifiants

pubmed: 30713310
doi: 10.2169/internalmedicine.1826-18
pmc: PMC6599923
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Pagination

1541-1547

Références

Gastroenterology. 2005 Aug;129(2):422-8
pubmed: 16083699
Gastroenterology. 2008 Jul;135(1):82-90
pubmed: 18482589
Lancet. 2010 May 8;375(9726):1624-33
pubmed: 20430429
Int J Cancer. 2012 Jun 15;130(12):2961-73
pubmed: 21792895
N Engl J Med. 2012 Feb 23;366(8):687-96
pubmed: 22356322
N Engl J Med. 2012 Jun 21;366(25):2345-57
pubmed: 22612596
N Engl J Med. 2013 Sep 19;369(12):1095-105
pubmed: 24047059
N Engl J Med. 2013 Sep 19;369(12):1106-14
pubmed: 24047060
Int J Clin Oncol. 2015 Apr;20(2):207-39
pubmed: 25782566
Nihon Shokakibyo Gakkai Zasshi. 2016 Jul;113(7):1176-85
pubmed: 27383100
Prev Med. 1994 May;23(3):309-13
pubmed: 8078851
N Engl J Med. 1993 May 13;328(19):1365-71
pubmed: 8474513
N Engl J Med. 1996 Jan 18;334(3):155-9
pubmed: 8531970
Lancet. 1996 Nov 30;348(9040):1472-7
pubmed: 8942775
Jpn J Cancer Res. 1996 Oct;87(10):1011-24
pubmed: 8957057

Auteurs

Ryo Yuge (R)

Department of Endoscopy, Hiroshima University Hospital, Japan.

Toshiko Fujii (T)

Department of Epidemiology, Infectious Disease Control and Prevention, Hiroshima University Institute of Biomedical and Health Sciences, Japan.
Hiroshima Regional Health Medical Promotion Organization, Japan.

Kei Shinagawa (K)

Department of Endoscopy, Hiroshima University Hospital, Japan.

Yoji Sanomura (Y)

Department of Endoscopy, Hiroshima University Hospital, Japan.

Shiro Oka (S)

Department of Endoscopy, Hiroshima University Hospital, Japan.

Shintaro Nagashima (S)

Department of Epidemiology, Infectious Disease Control and Prevention, Hiroshima University Institute of Biomedical and Health Sciences, Japan.

Masayuki Ohisa (M)

Department of Epidemiology, Infectious Disease Control and Prevention, Hiroshima University Institute of Biomedical and Health Sciences, Japan.

Yasuhiko Kitadai (Y)

Department of Health Sciences, Prefectural University of Hiroshima, Japan.

Shinji Tanaka (S)

Department of Endoscopy, Hiroshima University Hospital, Japan.

Nobuoki Kohno (N)

Hiroshima Cosmopolitan University, Japan.

Junko Tanaka (J)

Department of Epidemiology, Infectious Disease Control and Prevention, Hiroshima University Institute of Biomedical and Health Sciences, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH